Cardiovascular Risk Education and Social Support (CaRESS): Report of a Randomized Controlled Trial from the Kentucky Ambulatory Network (KAN)
Pearce et al.
J Am Board Fam Med 2008;21:269-281.
ABSTRACT
| FULL TEXT
Performance of Comorbidity Measures to Predict Stroke and Death in a Community-Dwelling, Hypertensive Medicaid Population
Tang et al.
Stroke 2008;39:1938-1944.
ABSTRACT
| FULL TEXT
Thiazide-Induced Dysglycemia: Call for Research From a Working Group From the National Heart, Lung, and Blood Institute
Carter et al.
Hypertension 2008;52:30-36.
FULL TEXT
Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force
ANN INTERN MED 2008;148:846-854.
ABSTRACT
| FULL TEXT
Effect of Board Certification on Antihypertensive Treatment Intensification in Patients With Diabetes Mellitus
Turchin et al.
Circulation 2008;117:623-628.
ABSTRACT
| FULL TEXT
Hyperresistinemia Is Associated With Coexistence of Hypertension and Type 2 Diabetes
Takata et al.
Hypertension 2008;51:534-539.
ABSTRACT
| FULL TEXT
Standards of Medical Care in Diabetes--2008
American Diabetes Association
Diabetes Care 2008;31:S12-S54.
FULL TEXT
Considerations for the Pharmacological Treatment of Diabetes in Older Adults
Odegard et al.
Diabetes Spectr. 2007;20:239-247.
FULL TEXT
Understanding the Quality Chasm for Hypertension Control in Diabetes: A Structured Review of "Co-maneuvers" Used in Clinical Trials
Naik et al.
J Am Board Fam Med 2007;20:469-478.
ABSTRACT
| FULL TEXT
Race and Ethnicity in Trials of Antihypertensive Therapy to Prevent Cardiovascular Outcomes: A Systematic Review
Park and Taylor
Ann Fam Med 2007;5:444-452.
ABSTRACT
| FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J Suppl 2007;9:C3-C74.
FULL TEXT
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study
Fox et al.
Circulation 2007;115:1544-1550.
ABSTRACT
| FULL TEXT
Blood pressure and ageing
Pinto
Postgrad. Med. J. 2007;83:109-114.
ABSTRACT
| FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J 2007;28:88-136.
FULL TEXT
Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999-2004
Ong et al.
Hypertension 2007;49:69-75.
ABSTRACT
| FULL TEXT
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
Dzau et al.
Circulation 2006;114:2850-2870.
FULL TEXT
Action or Inaction? Decision Making in Patients With Diabetes and Elevated Blood Pressure in Primary Care
Hicks et al.
Diabetes Care 2006;29:2580-2585.
ABSTRACT
| FULL TEXT
Fasting Glucose Levels and Incident Diabetes Mellitus in Older Nondiabetic Adults Randomized to Receive 3 Different Classes of Antihypertensive Treatment: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay et al.
Arch Intern Med 2006;166:2191-2201.
ABSTRACT
| FULL TEXT
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Circulation 2006;113:e873-e923.
ABSTRACT
| FULL TEXT
Impaired Glucose Tolerance Increases Stroke Risk in Nondiabetic Patients With Transient Ischemic Attack or Minor Ischemic Stroke
Vermeer et al.
Stroke 2006;37:1413-1417.
ABSTRACT
| FULL TEXT
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Stroke 2006;37:1583-1633.
ABSTRACT
| FULL TEXT
Antihypertensive Therapy and the Risk of New-Onset Diabetes
Sarafidis and Bakris
Diabetes Care 2006;29:1167-1169.
FULL TEXT
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco et al.
Circulation 2006;113:e409-e449.
ABSTRACT
| FULL TEXT
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco et al.
Stroke 2006;37:577-617.
ABSTRACT
| FULL TEXT
Management of Hypertension in Diabetes
Stults and Jones
Diabetes Spectr. 2006;19:25-31.
ABSTRACT
| FULL TEXT
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
Prepared by: British Cardiac Society, British Hype
Heart 2005;91:v1-v52.
FULL TEXT
Review: Blood pressure reduction in the metabolic syndrome and type 2 diabetes: current concepts
Schachter
British Journal of Diabetes & Vascular Disease 2005;5:320-324.
ABSTRACT
Antihypertensive Agents for Primary Prevention of Diabetic Nephropathy
Strippoli et al.
J. Am. Soc. Nephrol. 2005;16:3081-3091.
ABSTRACT
| FULL TEXT
Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Whelton et al.
Arch Intern Med 2005;165:1401-1409.
ABSTRACT
| FULL TEXT
Hypertension in type 2 diabetes - targeting angiotensin
DTB 2005;43:41-45.
ABSTRACT
| FULL TEXT
The cost of glucocorticoid-associated adverse events in rheumatoid arthritis
Pisu et al.
Rheumatology (Oxford) 2005;44:781-788.
ABSTRACT
| FULL TEXT
The Gender-Specific Impact of Diabetes and Myocardial Infarction at Baseline and During Follow-Up on Mortality From All Causes and Coronary Heart Disease
Hu et al.
J Am Coll Cardiol 2005;45:1413-1418.
ABSTRACT
| FULL TEXT
The European Association for the Study of Diabetes
Bloomgarden
Diabetes Care 2005;28:1250-1257.
FULL TEXT
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) study
Wachtell et al.
J Am Coll Cardiol 2005;45:705-711.
ABSTRACT
| FULL TEXT
Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
Ravera et al.
J. Am. Soc. Nephrol. 2005;16:S48-S52.
ABSTRACT
| FULL TEXT
The Effects of Cyclooxygenase-2 Inhibitors and Nonsteroidal Anti-inflammatory Therapy on 24-Hour Blood Pressure in Patients With Hypertension, Osteoarthritis, and Type 2 Diabetes Mellitus
Sowers et al.
Arch Intern Med 2005;165:161-168.
ABSTRACT
| FULL TEXT
Intensive Integrated Therapy of Type 2 Diabetes: Implications for Long-Term Prognosis
Gaede and Pedersen
Diabetes 2004;53:S39-S47.
ABSTRACT
| FULL TEXT
Trends in Cardiovascular Complications of Diabetes
Fox et al.
JAMA 2004;292:2495-2499.
ABSTRACT
| FULL TEXT
Treatment of Hypertension in Patients With Diabetes
Sowers
Arch Intern Med 2004;164:1850-1857.
ABSTRACT
| FULL TEXT
Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects: A 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm
Saad et al.
Diabetes Care 2004;27:1324-1329.
ABSTRACT
| FULL TEXT
The Impact of Vitamins and/or Mineral Supplementation on Blood Pressure in Type 2 Diabetes
Farvid et al.
J. Am. Coll. Nutr. 2004;23:272-279.
ABSTRACT
| FULL TEXT
Trends in Complexity of Diabetes Care in the United States From 1991 to 2000
Grant et al.
Arch Intern Med 2004;164:1134-1139.
ABSTRACT
| FULL TEXT
Women and Heart Disease: The Role of Diabetes and Hyperglycemia
Barrett-Connor et al.
Arch Intern Med 2004;164:934-942.
ABSTRACT
| FULL TEXT
Epidemiology of Diabetes
Winer and Sowers
J Clin Pharmacol 2004;44:397-405.
ABSTRACT
| FULL TEXT
Hypertension Management in the Diabetes Patient
Durst and Schering
Journal of Pharmacy Practice 2004;17:55-60.
ABSTRACT
Optimizing Therapy in the Diabetic Patient with Renal Disease: Antihypertensive Treatment
Deferrari et al.
J. Am. Soc. Nephrol. 2004;15:S6-11.
ABSTRACT
| FULL TEXT
Hypertension Control: How Well Are We Doing?
Borzecki et al.
Arch Intern Med 2003;163:2705-2711.
ABSTRACT
| FULL TEXT
Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management
Hurst and Lee
ANN INTERN MED 2003;139:824-834.
ABSTRACT
| FULL TEXT
Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPAR{alpha} and {gamma} Agonist in Healthy Subjects and Patients with Type 2 Diabetes
Skrumsager et al.
J Clin Pharmacol 2003;43:1244-1256.
ABSTRACT
| FULL TEXT
The JNC 7 Hypertension Guidelines
Murthy
JAMA 2003;290:1313-1313.
FULL TEXT
Effects of Blood Pressure Level on Progression of Diabetic Nephropathy: Results From the RENAAL Study
Bakris et al.
Arch Intern Med 2003;163:1555-1565.
ABSTRACT
| FULL TEXT
Blood pressure measurement in diabetes: theory and practice
Petrie
British Journal of Diabetes & Vascular Disease 2003;3:258-261.
ABSTRACT
Commonly asked questions: hypertension
Petrie and Kirby
British Journal of Diabetes & Vascular Disease 2003;3:270-273.
The ALLHAT Study
Goff
Clin. Diabetes 2003;21:102-104.
FULL TEXT
Prevention of Hypertension and Its Complications: Theoretical Basis and Guidelines for Treatment
Flack et al.
J. Am. Soc. Nephrol. 2003;14:S92-98.
ABSTRACT
| FULL TEXT
The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus
Snow et al.
ANN INTERN MED 2003;138:587-592.
ABSTRACT
| FULL TEXT
Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care
Vijan and Hayward
ANN INTERN MED 2003;138:593-602.
ABSTRACT
| FULL TEXT
Outcome beyond blood pressure control?
Staessen et al.
Eur Heart J 2003;24:504-514.
FULL TEXT
Prospective Analysis of Mortality, Morbidity, and Risk Factors in Elderly Diabetic Subjects: Nagano Study
Katakura et al.
Diabetes Care 2003;26:638-644.
ABSTRACT
| FULL TEXT
Hypertension Management in Patients With Diabetes: The need for more aggressive therapy
Berlowitz et al.
Diabetes Care 2003;26:355-359.
ABSTRACT
| FULL TEXT
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
Gaede et al.
NEJM 2003;348:383-393.
ABSTRACT
| FULL TEXT
Cardiovascular Disease in Type 2 Diabetes Mellitus: Current Management Guidelines
Mooradian
Arch Intern Med 2003;163:33-40.
ABSTRACT
| FULL TEXT
Diabetology for cardiologists
Laakso and Kuusisto
Eur Heart J Suppl 2003;5:B5-B13.
ABSTRACT
Prevention of macrovascular complications
Fisher
Eur Heart J Suppl 2003;5:B21-B26.
ABSTRACT
Renal and Cardiovascular Protection in Type 2 Diabetes Mellitus: Angiotensin II Receptor Blockers
Deferrari et al.
J. Am. Soc. Nephrol. 2002;13:S224-229.
ABSTRACT
| FULL TEXT
Common Drug Pathways and Interactions
Kroner
Diabetes Spectr. 2002;15:249-255.
ABSTRACT
| FULL TEXT
Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus
Barr et al.
ANN INTERN MED 2002;137:263-272.
ABSTRACT
| FULL TEXT
The Impact of Clinical Trials on the Treatment of Diabetes Mellitus
Nathan
J. Clin. Endocrinol. Metab. 2002;87:1929-1937.
ABSTRACT
| FULL TEXT
Special management needs of the elderly hypertensive patient
Elliott and McInnes
Journal of Renin-Angiotensin-Aldosterone System 2002;3:S25-S31.
Therapy in the elderly hypertensive
Meredith and Trenkwalder
Journal of Renin-Angiotensin-Aldosterone System 2002;3:S49-S56.
ABSTRACT
Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Guidelines Based on Current Evidence
Kaplan
ANN INTERN MED 2001;135:1079-1083.
ABSTRACT
| FULL TEXT
Reduced Cardiovascular Morbidity and Mortality in Hypertensive Diabetic Patients on First-Line Therapy With an ACE Inhibitor Compared With a Diuretic/{beta}-Blocker-Based Treatment Regimen: A subanalysis of the Captopril Prevention Project
Niskanen et al.
Diabetes Care 2001;24:2091-2096.
ABSTRACT
| FULL TEXT
Vascular complications in diabetes and their prevention
Kassab et al.
Vasc Med 2001;6:249-255.
ABSTRACT
Randomised controlled trial of structured personal care of type 2 diabetes mellitus
Olivarius et al.
BMJ 2001;323:970-970.
ABSTRACT
| FULL TEXT
Treatment of Isolated Systolic Hypertension Is Most Effective in Older Patients With High-Risk Profile
Ferrucci et al.
Circulation 2001;104:1923-1926.
ABSTRACT
| FULL TEXT
The Diabetes Quality Improvement Project: Moving science into health policy to gain an edge on the diabetes epidemic
Fleming et al.
Diabetes Care 2001;24:1815-1820.
FULL TEXT
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
Lewis et al.
NEJM 2001;345:851-860.
ABSTRACT
| FULL TEXT
Developing a Prediction Rule From Automated Clinical Databases to Identify High-Risk Patients in a Large Population With Diabetes
Selby et al.
Diabetes Care 2001;24:1547-1555.
ABSTRACT
| FULL TEXT
Blood Pressure Control and Benefits of Antihypertensive Therapy: Does It Make a Difference Which Agents We Use?
Ruilope and Schiffrin
Hypertension 2001;38:537-542.
ABSTRACT
| FULL TEXT
Treatment of Obesity Hypertension and Diabetes Syndrome
Zanella et al.
Hypertension 2001;38:705-708.
ABSTRACT
| FULL TEXT
The American Diabetes Association's 48th Annual Advanced Postgraduate Course
Bloomgarden
Diabetes Care 2001;24:1489-1495.
FULL TEXT
Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension
Kario et al.
J Am Coll Cardiol 2001;38:238-245.
ABSTRACT
| FULL TEXT
Baseline Characteristics of the Diabetic Participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Barzilay et al.
Diabetes Care 2001;24:654-658.
ABSTRACT
| FULL TEXT
Diabetes, Hypertension, and Cardiovascular Disease : An Update
Sowers et al.
Hypertension 2001;37:1053-1059.
ABSTRACT
| FULL TEXT
Inferiority of calcium channel blockers to cheaper drugs
Kaplan et al.
BMJ 2001;322:671a-671.
FULL TEXT
Review: The management of the elderly with hypertension
Bulpitt
Journal of Renin-Angiotensin-Aldosterone System 2001;2:11-13.
Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Goldstein et al.
Circulation 2001;103:163-182.
FULL TEXT
Diabetes in Elderly Adults
Meneilly and Tessier
J. Gerontol. A Biol. Sci. Med. Sci. 2001;56:5M-13.
ABSTRACT
| FULL TEXT
Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Goldstein et al.
Stroke 2001;32:280-299.
FULL TEXT
What Is the Best Evidence for Making Clinical Decisions?
Shah et al.
JAMA 2000;284:3127-3128.
FULL TEXT
Variations in the Care of Elderly Persons With Diabetes Among Endocrinologists, General Internists, and Geriatricians
Chin et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2000;55:601M-606.
ABSTRACT
| FULL TEXT
Managing cardiovascular risk in patients with diabetes
Rydén
Heart 2000;84:23i-25.
FULL TEXT
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
Adler et al.
BMJ 2000;321:412-419.
ABSTRACT
| FULL TEXT
Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1: Thiazide diuretics
Wright
CMAJ 2000;163:57-60.
ABSTRACT
| FULL TEXT
Optimizing Treatment of Hypertension in Patients With Diabetes
Cooper and Johnston
JAMA 2000;283:3177-3179.
FULL TEXT
Hypertension and Diabetes: New Therapeutic Options
Deedwania
Arch Intern Med 2000;160:1585-1594.
ABSTRACT
| FULL TEXT
Cardiac, renal and vascular complications in the diabetic patient
Zanchetti
Journal of Renin-Angiotensin-Aldosterone System 2000;1:S21-S24.
ABSTRACT
